Treatment interruption: study found poor result for highly treated, highly resistant patients.

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Antiretroviral therapy (ART) is crucial for managing human immunodeficiency virus (HIV) infection.
• Treatment interruptions are sometimes considered in HIV management, but their efficacy is debated, especially in cases of drug resistance.

Discussion:

• This study investigated the impact of a four-month structured treatment interruption (STI) on viral load and drug resistance in HIV-positive patients.
• Patients included in this study had suboptimal viral suppression despite ongoing ART, indicating significant drug resistance.
• The STI strategy was evaluated for its potential to improve treatment outcomes or simplify regimens.

Key Insights:

• A four-month treatment interruption failed to achieve viral control in patients with pre-existing extensive HIV drug resistance.
• The underlying extensive resistance mutations persisted, rendering the virus unresponsive to standard antiretroviral drugs even after the interruption period.
• This finding highlights the critical role of sustained viral suppression and the limitations of treatment interruptions in the presence of advanced drug resistance.

Outlook:

• Future research should focus on optimizing treatment strategies for patients with multidrug-resistant HIV.
• Developing novel antiretroviral agents or combination therapies is essential for managing treatment-experienced individuals.
• Personalized medicine approaches, guided by comprehensive resistance testing, are crucial for effective long-term HIV management.